Data as of Sep 30, 2026, 6:36 AM
Trades Apr 26, 2023 – Mar 31, 2026
Issuer
4 politicians disclosed trades in NVS (Novartis AG) between Apr 26, 2023 – Mar 31, 2026.
Trades
14
Politicians
4
Buy vol.
$121.0k
Sell vol.
$40.0k
Sector
A sale may close the position; filings are not a live holdings snapshot.
| Name | Last trade | Buys | Sells | Est. volume |
|---|---|---|---|---|
| Alan Armstrong | Mar 31, 2026 | 2 | 0 | $40.5k |
| Sheldon Whitehouse | Apr 9, 2024 | 1 | 1 | $40.5k |
| Thomas R Carper | Apr 26, 2023 | 1 | 0 | $8,001 |
| Name | Last trade | Buys | Sells | Est. volume |
|---|---|---|---|---|
| Lisa McClain | Oct 31, 2025 | 5 | 4 | $72.0k |
| Name | Last trade | Buys | Sells | Est. volume |
|---|---|---|---|---|
| Sheldon Whitehouse | Apr 9, 2024 | 1 | 1 | $40.5k |
| Thomas R Carper | Apr 26, 2023 | 1 | 0 | $8,001 |
| Name | Last trade | Buys | Sells | Est. volume |
|---|---|---|---|---|
| Lisa McClain | Oct 31, 2025 | 5 | 4 | $72.0k |
| Alan Armstrong | Mar 31, 2026 | 2 | 0 | $40.5k |
| Politician | Traded issuer | Sector | Type | Size | Traded | Trade price | Yesterday | Published | Filed after |
|---|---|---|---|---|---|---|---|---|---|
| Alan Armstrong | Novartis AGNVS | Healthcare | Purchase | $1k–$15k | Mar 31, 2026 | $152.75 | $145.71 | Jul 21, 2026 | 112 days |
| Alan Armstrong | Novartis AGNVS | Healthcare | Purchase | $15k–$50k | Mar 30, 2026 | $150.36 | $145.71 | Jul 21, 2026 | 113 days |
| Lisa McClain | Novartis AGNVS | Healthcare | Sale | $1k–$15k | Oct 31, 2025 | $123.79 | $145.71* | Nov 21, 2025 | 21 days |
| Lisa McClain | Novartis AGNVS | Healthcare | Purchase | $1k–$15k | Oct 30, 2025 | $122.61 | $145.71* | Nov 21, 2025 | 22 days |
| Lisa McClain | Novartis AGNVS | Healthcare | Sale | $1k–$15k | Sep 25, 2025 | $122.23 | $145.71* | Oct 22, 2025 | 27 days |
| Lisa McClain | Novartis AGNVS | Healthcare | Purchase | $1k–$15k | Sep 11, 2025 | $127.70 | $145.71* | Oct 22, 2025 | 41 days |
| Lisa McClain | Novartis AGNVS | Healthcare | Sale | $1k–$15k | Jul 22, 2025 | $116.83 | $145.71* | Aug 13, 2025 | 22 days |
| Lisa McClain | Novartis AGNVS | Healthcare | Purchase | $1k–$15k | Jun 17, 2025 | $116.41 | $145.71* | Aug 13, 2025 | 57 days |
| Lisa McClain | Novartis AGNVS | Healthcare | Purchase | $1k–$15k | Jun 11, 2025 | $118.07 | $145.71* | Aug 13, 2025 | 63 days |
| Lisa McClain | Novartis AGNVS | Healthcare | Sale | $1k–$15k | Jun 10, 2025 | $118.58 | $145.71* | Aug 13, 2025 | 64 days |
| Lisa McClain | Novartis AGNVS | Healthcare | Purchase | $1k–$15k | Jun 9, 2025 | $118.02 | $145.71* | Aug 13, 2025 | 65 days |
| Sheldon Whitehouse | Novartis AGNVS | Healthcare | Sale | $1k–$15k | Apr 9, 2024 | $95.81 | $145.71* | May 20, 2024 | 41 days |
| Sheldon Whitehouse | Novartis AGNVS | Healthcare | Purchase | $15k–$50k | Sep 20, 2023 | $103.58 | $145.71* | Oct 17, 2023 | 27 days |
| Thomas R Carper | Novartis AGNVS | Healthcare | Purchase | $1k–$15k | Apr 26, 2023 | $102.54 | $145.71* | May 1, 2023 | 5 days |
Download NVS congressional trades (CSV)Every politician who disclosed a trade in this symbol in the current snapshot.
RSS for NVSNew congressional filings in this symbol, by filing date.
Educated guesstimate only. Filings report ranges, not exact sizes. Share counts use the range midpoint (or 1.5× the floor for “Over $X”) and the closing price on the trade date. Open lots are marked to the latest Yahoo Finance close. Cash dividends and split factors are applied while a reconstructed lot is open. Sales with no matching disclosed buy are treated as closing an unseen lot at the sale price (about $0 P/L on that slice). Bonds and rows without a usable ticker are excluded. This is not actual profit.